# A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease

> **NCT01305824** · PHASE2 · COMPLETED · sponsor: **Proteon Therapeutics** · enrollment: 151 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** PRT-201
- **DRUG:** Placebo
- **DRUG:** PRT-201

## Key facts

- **NCT ID:** NCT01305824
- **Lead sponsor:** Proteon Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2015-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01305824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01305824, "A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01305824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*